CVC  NVentures

https://www.nventures.ai/





     Office Locations:

2788 San Tomas Expressway
Santa Clara, CA 95051

 

Stages:

  • Early


 

Industries:

  • Electronics & Advanced Materials
  • Information Technology
  • Semiconductor
  • Software & Internet

  •  

    Description:

    NVentures is NVIDIA's venture capital arm. The firm invests in technology visionaries solving complex problems to reshape our world. Through a unique mix of expertise and resources, NVentures build long-term partnerships with bold teams to accelerate their journeys.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Artem Barsukov Investment Director
    Mohamed (Sid) Siddeek Head of NVentures

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/11/2024


      Neocis


      FL


      $20,000,000


      


      10/30/2023


      Seurat Technologies


      MA


      $99,000,000


      Series C


      10/05/2023


      Machina Labs


      CA


      $32,000,000


      Series B


      09/29/2023


      Evozyne


      IL


      $81,000,000


      Series B


      09/14/2023


      Generate:Biomedicines


      MA


      $273,000,000


      Series C


      08/21/2023


      Genesis Therapeutics


      CA


      $200,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: